| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2008-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df7a72b8af3448371b0d29dcd13681c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_281df5e3a0da83436e237939caace464 |
| publicationDate |
2009-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009105141-A1 |
| titleOfInvention |
Intraventricular protein delivery for amyotrophic lateral sclerosis |
| abstract |
Amyotrophic Lateral Sclerosis can be successfully treated using intraventricular delivery of a neurotrophic growth factor, IGF-1. The administration can be performed slowly to achieve maximum effect. Effects are seen on both sides of the blood-brain barrier, making this a delivery means for Amyotrophic Lateral Sclerosis which affects both brain and skeletal muscle. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10140708-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10080783-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10354380-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009123451-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018336681-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253485-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021198312-A1 |
| priorityDate |
2006-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |